TY - JOUR T1 - Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients JF - Hepatology Y1 - 2014 A1 - Hsu, Y.C. A1 - Lin, J.T. A1 - Ho, H.J. A1 - Kao, Y.H. A1 - Huang, Y.T. A1 - Hsiao, N.W. A1 - Wu, M.S. A1 - Liu, Y.Y. A1 - Wu, C.Y. KW - Acute Coronary Syndrome KW - Adult KW - Aged KW - Antibodies KW - Antiviral Agents KW - China KW - clinical trial KW - Cohort Studies KW - Comorbidity KW - Diabetes Mellitus KW - diagnosis KW - Disease KW - drug therapy KW - Drug Therapy,Combination KW - epidemiology KW - Female KW - Follow-Up Studies KW - Gastroenterology KW - HCV KW - Health KW - hepatitis KW - Hepatitis C KW - hepatitis C virus KW - Humans KW - Incidence KW - Infection KW - Insulin KW - Insulin Resistance KW - interferon KW - Interferon-alpha KW - Kidney Failure,Chronic KW - Male KW - Medicine KW - Middle Aged KW - Multivariate Analysis KW - Patients KW - peginterferon KW - pegylated KW - pegylated interferon KW - Polyethylene Glycols KW - prevention & control KW - Proteins KW - Recombinant Proteins KW - Renal KW - Research KW - Research Support KW - resistance KW - Ribavirin KW - Risk Factors KW - Serum KW - Stroke KW - Syndrome KW - Taiwan KW - therapeutic use KW - therapy KW - treatment KW - Treatment Outcome VL - 59 SP - 1293-1302 IS - 4 ER -